Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis

Acta Dermato-Venereologica

Volumn 90, Issue 1, 2010, Pages 52-57

  Alsterholm, Mikael ^a   Flytström, Ingela ^a   Bergbrant, Ing Marie ^a   Faergemann, Jan ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atopic dermatitis; Fusidic acid; Impetigo; Staphylococcus aureus

Indexed keywords

FUSIDIC ACID;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ATOPIC DERMATITIS; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; IMPETIGO; IMPETIGO BULLOSA; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLISTER; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DRUG RESISTANCE, BACTERIAL; FEMALE; FUSIDIC ACID; HUMANS; IMPETIGO; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS AUREUS; SWEDEN; YOUNG ADULT;

EID: 76349120172     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0771     Document Type: Article

References (27)

1. Howden BP, Grayson ML. Dumb and dumber - the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006; 42: 394-400.
2. Shanson DC. Clinical relevance of resistance to fusidic acid in Staphylococcus aureus. J Antimicrob Chemother 1990; 25 Suppl B: 15-21.
3. Osterlund A, Eden T, Olsson-Liljequist B, Haeggman S, Kahlmeter G. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002; 34: 729-734.
4. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002; 50: 873-876.
5. Brown EM, Thomas P. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 2002; 359: 803.
6. Brown EM, Wise R. Fusidic acid cream for impetigo. Fusidic acid should be used with restraint. Br Med J 2002; 324: 1394.
7. Treatment of impetigo. Swedish Medical Products Agency. 2003. Available from: http://www.lakemedelsverket.se/Tpl/RecommendationsPage-2979.aspx
8. Larsen AR, Skov RL, Jarlier V, Henriksen AS. Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections. J Antimicrob Chemother 2008; 61: 589-594.
9. Denton M, O'Connell B, Bernard P, Jarlier V, Williams Z, Henriksen AS. The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother 2008; 61: 586-588.
10. Laurent F, Tristan A, Croze M, Bes M, Meugnier H, Lina G, et al. Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France. J Antimicrob Chemother 2009; 63: 420-421.
11. O'Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007; 45: 1505-1510.
12. O'Neill AJ, Larsen AR, Henriksen AS, Chopra I. A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates. Antimicrob Agents Chemother 2004; 48: 3594-3597.
13. O'Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother 2007; 51: 1737-1740.
14. O'Neill AJ, Chopra I. Molecular basis of fusB-mediated resistance to fusidic acid in Staphylococcus aureus. Mol Microbiol 2006; 59: 664-676.
15. Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol 1998; 139 Suppl 53: 13-16.
16. Sule O, Brown NM, Willocks LJ, Day J, Shankar S, Palmer CR, et al. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use. Int J Antimicrob Agents 2007; 30: 78-82.
17. Peeters KA. Resistance of Staphylococcus aureus to fusidic acid. Int J Dermatol 2004; 43: 235.
18. Hoeger PH. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr Allergy Immunol 2004; 15: 474.
19. Niebuhr M, Mai U, Kapp A, Werfel T. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol 2008; 17: 953-957.
20. Antimicrobial resistance surveillance in Sweden: ResNet. 2009. Available from: http://www.srga.org/ResNet-sok.htm
21. Osterlund A, Kahlmeter G, Haeggman S, Olsson-Liljequist B. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study. Scand J Infect Dis 2006; 38: 334.
22. Mitra A, Mohanraj M, Shah M. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use. Clin Exp Dermatol 2009; 34: 136-139.
23. Ravenscroft JC. Observations on high levels of fusidic acid resistant Staphylococcus. Clin Exp Dermatol 2000; 25: 327.
24. Ravenscroft JC, Layton AM, Eady EA, Murtagh MS, Coates P, Walker M, et al. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003; 148: 1010-1017.
25. Mason BW, Howard AJ. Fusidic acid resistance in community isolates of methicillin susceptible Staphylococcus aureus and the use of topical fusidic acid: a retrospective case-control study. Int J Antimicrob Agents 2004; 23: 300-303.
26. Whitman TJ. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Dis Mon 2008; 54: 780-786.
27. Jappe U, Heuck D, Strommenger B, Wendt C, Werner G, Altmann D, et al. Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 2008; 128: 2655-2664.